The estimated Net Worth of Amelia Merrill is at least $1.17 Milión dollars as of 1 March 2024. Ms Merrill owns over 158 units of Guardant Health Inc stock worth over $684,920 and over the last 2 years she sold GH stock worth over $484,650.
Ms has made over 13 trades of the Guardant Health Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she exercised 158 units of GH stock worth $3,929 on 1 March 2024.
The largest trade she's ever made was selling 9,000 units of Guardant Health Inc stock on 11 August 2022 worth over $484,650. On average, Ms trades about 1,193 units every 36 days since 2022. As of 1 March 2024 she still owns at least 27,540 units of Guardant Health Inc stock.
You can see the complete history of Ms Merrill stock trades at the bottom of the page.
Amelia Merrill is the VP of People at Guardant Health Inc.
Amelia's mailing address filed with the SEC is 3100, Hanover Street, Palo Alto, Santa Clara County, California, 94306, United States.
Over the last 6 years, insiders at Guardant Health Inc have traded over $2,653,630,540 worth of Guardant Health Inc stock and bought 2,438,210 units worth $45,173,576 . The most active insiders traders include Bluebird (Cayman) Ltd Softb..., Bluebird (Cayman) Ltd Svf E... a Helmy Eltoukhy. On average, Guardant Health Inc executives and independent directors trade stock every 6 days with the average trade being worth of $2,415,822. The most recent stock trade was executed by Kumud Kalia on 9 September 2024, trading 6,545 units of GH stock currently worth $162,774.
we believe conquering cancer is a big data problem. that’s why we built the world’s leading comprehensive liquid biopsy. this non-invasive tool for accessing and sequencing tumor dna is used by thousands of oncologists to help tens of thousands of advanced cancer patients. we believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. we’re working on some exciting ones, including in early detection, where the impact on patients can be profound. we’ve raised more than $500 million from investors including sequoia capital, khosla ventures, orbimed, and softbank.
Guardant Health Inc executives and other stock owners filed with the SEC include: